Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 2
2003 1
2004 5
2005 2
2006 2
2007 2
2008 5
2009 4
2010 8
2011 11
2012 11
2013 8
2014 7
2015 4
2016 4
2017 6
2018 5
2019 4
2020 2
2021 2
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction.
Ouweneel DM, Eriksen E, Sjauw KD, van Dongen IM, Hirsch A, Packer EJ, Vis MM, Wykrzykowska JJ, Koch KT, Baan J, de Winter RJ, Piek JJ, Lagrand WK, de Mol BA, Tijssen JG, Henriques JP. Ouweneel DM, et al. J Am Coll Cardiol. 2017 Jan 24;69(3):278-287. doi: 10.1016/j.jacc.2016.10.022. Epub 2016 Oct 31. J Am Coll Cardiol. 2017. PMID: 27810347 Free article. Clinical Trial.
BACKGROUND: Despite advances in treatment, mortality in acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) remains high. Short-term mechanical circulatory support devices acutely improve hemodynamic conditions. ...
BACKGROUND: Despite advances in treatment, mortality in acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) remains high …
Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials.
Fiolet ATL, Opstal TSJ, Mosterd A, Eikelboom JW, Jolly SS, Keech AC, Kelly P, Tong DC, Layland J, Nidorf SM, Thompson PL, Budgeon C, Tijssen JGP, Cornel JH. Fiolet ATL, et al. Among authors: tijssen jgp. Eur Heart J. 2021 Jul 21;42(28):2765-2775. doi: 10.1093/eurheartj/ehab115. Eur Heart J. 2021. PMID: 33769515
METHODS AND RESULTS: We searched the literature for randomized clinical trials of long-term colchicine in patients with atherosclerosis published up to 1 September 2020. ...
METHODS AND RESULTS: We searched the literature for randomized clinical trials of long-term colchicine in patients with atheroscleros …
Long-Term Efficacy of Colchicine in Patients With Chronic Coronary Disease: Insights From LoDoCo2.
Opstal TSJ, van Broekhoven A, Fiolet ATL, Mosterd A, Eikelboom JW, Nidorf SM, Thompson PL, Budgeon CA, Bartels L, de Nooijer R, Bax WA, Tijssen JGP, El Messaoudi S, Cornel JH. Opstal TSJ, et al. Among authors: tijssen jgp. Circulation. 2022 Feb 22;145(8):626-628. doi: 10.1161/CIRCULATIONAHA.121.058233. Epub 2022 Feb 21. Circulation. 2022. PMID: 35188792 Clinical Trial. No abstract available.
Long-term impact of chronic total occlusion recanalisation in patients with ST-elevation myocardial infarction.
Elias J, van Dongen IM, Råmunddal T, Laanmets P, Eriksen E, Meuwissen M, Michels HR, Bax M, Ioanes D, Suttorp MJ, Strauss BH, Barbato E, Marques KM, Claessen BEPM, Hirsch A, van der Schaaf RJ, Tijssen JGP, Henriques JPS, Hoebers LP; EXPLORE investigators. Elias J, et al. Among authors: tijssen jgp. Heart. 2018 Sep;104(17):1432-1438. doi: 10.1136/heartjnl-2017-312698. Epub 2018 Feb 20. Heart. 2018. PMID: 29463612 Clinical Trial.
Our aim was to determine mid-term and long-term clinical outcome of CTO-PCI versus CTO-No PCI in patients with STEMI with a concurrent CTO. ...CONCLUSIONS: In this randomised trial involving patients with STEMI with a concurrent CTO, CTO-PCI was not associated with …
Our aim was to determine mid-term and long-term clinical outcome of CTO-PCI versus CTO-No PCI in patients with STEMI with a co …
Colchicine and diabetes in patients with chronic coronary artery disease: insights from the LoDoCo2 randomized controlled trial.
Mohammadnia N, Los J, Opstal TSJ, Fiolet ATL, Eikelboom JW, Mosterd A, Nidorf SM, Budgeon CA, Tijssen JGP, Thompson PL, Tack CJ, Simsek S, Bax WA, Cornel JH, El Messaoudi S. Mohammadnia N, et al. Among authors: tijssen jgp. Front Cardiovasc Med. 2023 Oct 6;10:1244529. doi: 10.3389/fcvm.2023.1244529. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37868776 Free PMC article.
The effect of its treatment in patients with and without DM was evaluated by including an interaction term in the model. RESULTS: A total of 1,007 participants (18.2%) had T2DM at baseline. ...
The effect of its treatment in patients with and without DM was evaluated by including an interaction term in the model. RESULTS: A t …
Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data.
Fox KA, Clayton TC, Damman P, Pocock SJ, de Winter RJ, Tijssen JG, Lagerqvist B, Wallentin L; FIR Collaboration. Fox KA, et al. J Am Coll Cardiol. 2010 Jun 1;55(22):2435-45. doi: 10.1016/j.jacc.2010.03.007. Epub 2010 Mar 30. J Am Coll Cardiol. 2010. PMID: 20359842 Free article. Review.
OBJECTIVES: This study was designed to determine: 1) whether a routine invasive (RI) strategy reduces the long-term frequency of cardiovascular death or nonfatal myocardial infarction (MI) using a meta-analysis of individual patient data from all randomized studies with 5- …
OBJECTIVES: This study was designed to determine: 1) whether a routine invasive (RI) strategy reduces the long-term frequency of card …
Long-term (>10-year) clinical follow-up after young embolic stroke/TIA of undetermined source.
Nassif M, Annink ME, Yang H, Rettig T, Roos Y, van den Brink R, Tijssen J, Mulder B, de Winter RJ, Bouma BJ. Nassif M, et al. Among authors: tijssen j. Int J Stroke. 2021 Jan;16(1):7-11. doi: 10.1177/1747493019884520. Epub 2019 Nov 3. Int J Stroke. 2021. PMID: 31679479 Free PMC article.
AIMS: Our aim was to study the long-term (>10-year) clinical outcome of young patients (<50 years) with ESUS. ...CONCLUSIONS: The incidence of recurrent stroke/TIA is relatively high during long-term clinical follow-up of young patients with ESUS. In contrast, …
AIMS: Our aim was to study the long-term (>10-year) clinical outcome of young patients (<50 years) with ESUS. ...CONCLUSIONS: T …
Effects of age on long-term outcomes after a routine invasive or selective invasive strategy in patients presenting with non-ST segment elevation acute coronary syndromes: a collaborative analysis of individual data from the FRISC II - ICTUS - RITA-3 (FIR) trials.
Damman P, Clayton T, Wallentin L, Lagerqvist B, Fox KA, Hirsch A, Windhausen F, Swahn E, Pocock SJ, Tijssen JG, de Winter RJ. Damman P, et al. Heart. 2012 Feb;98(3):207-13. doi: 10.1136/heartjnl-2011-300453. Epub 2011 Sep 19. Heart. 2012. PMID: 21930723 Review.
CONCLUSION: The current analysis of the FIR dataset shows that the long-term benefit of the routine invasive strategy over the selective invasive strategy is attenuated in younger patients aged <65 years and in women by the increased risk of early events which seem to h …
CONCLUSION: The current analysis of the FIR dataset shows that the long-term benefit of the routine invasive strategy over the select …
Beta blockers in heart failure haemodynamics, clinical effects and modes of action.
de Milliano PA, Tijssen JG, van Zwieten PA, Lie KI. de Milliano PA, et al. Neth Heart J. 2001 Nov;9(8):334-342. Neth Heart J. 2001. PMID: 25696756 Free PMC article. Review.
Indeed, many of these drugs may even lead to untoward long-term clinical outcomes as has been shown for example for milrinone and ibopamine. ...More recently, beta-blockers, which antagonise the activated sympathetic system, were shown to be beneficial in the long term …
Indeed, many of these drugs may even lead to untoward long-term clinical outcomes as has been shown for example for milrinone and ibo …
Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial.
Kerkmeijer LSM, Renkens MPL, Tijssen RYG, Hofma SH, van der Schaaf RJ, Arkenbout EK, Weevers APJD, Garcia-Garcia HM, Kraak R, Piek JJ, Tijssen JGP, Henriques JPS, de Winter RJ, Wykrzykowska JJ. Kerkmeijer LSM, et al. Among authors: tijssen jgp. EuroIntervention. 2022 Mar 18;17(16):1340-1347. doi: 10.4244/EIJ-D-21-00419. EuroIntervention. 2022. PMID: 34483094 Free PMC article. Clinical Trial.
85 results